HCMNY
TMO icon

Howard Capital Management (New York)’s Thermo Fisher Scientific TMO Stock Holding History

Howard Capital Management (New York)’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$25.1M Buy
53,852
+214
+0.4% +$100K 2.81% 11
2020
Q3 		$23.7M Buy
53,638
+295
+0.6% +$122K 2.99% 10
2020
Q2 		$19.3M Buy
53,343
+22
+0% +$7.37K 2.57% 13
2020
Q1 		$15.1M Sell
53,321
-730
-1% -$230K 2.58% 12
2019
Q4 		$17.6M Sell
54,051
-100
-0.2% -$30.3K 2.2% 17
2019
Q3 		$15.8M Sell
54,151
-400
-0.7% -$115K 2.25% 18
2019
Q2 		$16M Sell
54,551
-139
-0.3% -$38.3K 2.19% 18
2019
Q1 		$15M Buy
54,690
+2,664
+5% +$663K 2.11% 16
2018
Q4 		$11.6M Sell
52,026
-85
-0.2% -$19.9K 1.92% 21
2018
Q3 		$12.7M Buy
52,111
+95
+0.2% +$21.9K 1.7% 26
2018
Q2 		$10.8M Buy
52,016
+341
+0.7% +$72.4K 1.55% 32
2018
Q1 		$10.7M Buy
51,675
+1,030
+2% +$216K 1.55% 33
2017
Q4 		$9.62M Buy
50,645
+30
+0.1% +$5.75K 1.41% 34
2017
Q3 		$9.58M Buy
50,615
+3,250
+7% +$589K 1.48% 33
2017
Q2 		$8.26M Buy
+47,365
New +$7.96M 1.3% 36

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Howard Capital Management (New York)'s TMO Position: Q4 2020 in Review

Howard Capital Management (New York) increased its Thermo Fisher Scientific (TMO) stake by 0.4% in Q4 2020, buying an estimated $100K and bringing the position to 53,852 shares worth $25.1M. The position accounts for 2.81% of the portfolio, ranked #11.

Howard Capital Management (New York) first reported a position in TMO in Q2 2017 and has held it in 15 quarters since. 2,030 funds tracked by Wall St. Rank hold TMO as of Q4 2020.

  • Howard Capital Management (New York) held 53,852 shares of Thermo Fisher Scientific worth $25.1M as of Q4 2020.
  • Howard Capital Management (New York) bought 214 Thermo Fisher Scientific shares in Q4 2020, an estimated $100K.
  • Thermo Fisher Scientific made up 2.81% of Howard Capital Management (New York)'s portfolio in Q4 2020, its #11 holding.
  • Howard Capital Management (New York) first reported a position in Thermo Fisher Scientific in Q2 2017 and has held it in 15 quarters since.
  • 2,030 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2020.

Based on Howard Capital Management (New York)'s 13F filing for Q4 2020, filed 2 Feb 2021.